west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "指南更新" 4 results
  • The interpretation of the 2017 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: Adult Basic Life Support and Cardiopulmonary Resuscitation Quality

    The American Heart Association (AHA) released the 2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality (2017 AHA guidelines update) in November 2017. The 2017 AHA guidelines update was updated according to the rules named " the update of the guideline is no longer released every five years, but whenever new evidence is available” in the 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. The updated content in this guideline included five parts: dispatch-assisted cardiopulmonary resuscitation (CPR), bystander CPR, emergency medical services - delivered CRP, CRP for cardiac arrest, and chest compression - to - ventilation ratio. This review will interpret the 2017 AHA guidelines update in detail.

    Release date:2017-11-24 10:58 Export PDF Favorites Scan
  • 2017 年美国心脏病学会/美国心脏协会心脏瓣膜病患者管理指南更新:要点解读及前景展望

    自 2014 版美国心脏病学会(American College of Cardiology,ACC)/美国心脏协会(American Heart Association,AHA)心脏瓣膜病患者管理指南发布以来,心脏瓣膜病的治疗领域又取得了一些重要进展。此次更新的内容主要涉及主动脉瓣狭窄治疗方式的选择、二尖瓣反流的干预策略、人工瓣膜类型的选择以及生物瓣的抗栓治疗策略。该文对 2017 年 ACC/AHA 指南更新的主要内容进行了总结和解读,并在此基础上对心脏瓣膜病治疗领域的未来发展趋势进行了展望。

    Release date:2018-02-26 05:32 Export PDF Favorites Scan
  • 2017 欧洲心脏病学会/欧洲心胸外科协会心脏瓣膜病管理指南中经导管主动脉瓣置换术相关更新解读

    自2012欧洲心脏协会/欧洲心胸外科协会关于心脏瓣膜病的管理指南发布以来,新的临床证据又大量积累。这些新证据使欧洲心脏协会/欧洲心胸外科协会需要更新瓣膜病的管理指南以达到心内科与心外科医师间的共识。该文将从经导管主动脉瓣置换术出发,解读2017年新指南所作出的更新。

    Release date:2018-02-26 05:32 Export PDF Favorites Scan
  • Interpretation of updated NCCN guidelines for non-small cell lung cancer (version 1, 2022)

    The National Comprehensive Cancer Network (NCCN) has updated and released the latest content of the NCCN guidelines for the clinical diagnosis and treatment of non-small cell lung cancer (NSCLC) in the version 1, 2022. Based on high-quality clinical evidence and the latest research progress of the diagnosis and treatment of NSCLC, the guidelines have been widely recognized and welcomed by clinicians around the world. Compared with the version 7, 2021, the new version has been updated and revised in some parts of chapters and sections, mainly focusing on targeted therapies and molecular testing. This article will interpret the updated therapy content of the new version.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content